Status:
COMPLETED
Lidocaine for Pain After Urodynamic Testing
Lead Sponsor:
Atlantic Health System
Conditions:
Voiding Disorders
Overactive Bladder
Eligibility:
FEMALE
40-80 years
Phase:
PHASE4
Brief Summary
Urodynamic testing can be associated with mild discomfort, particularly at the time of insertion, repositioning, and removal of the bladder catheter (a tube inserted into the bladder via the urethra)....
Detailed Description
Urodynamic testing can be associated with mild discomfort, particularly at the time of insertion, repositioning, and removal of the bladder catheter (a tube inserted into the bladder via the urethra)....
Eligibility Criteria
Inclusion
- • All female patients between the ages of 40-80 undergoing urodynamic testing.
Exclusion
- Urinary tract infection or symptoms of infection at time of procedure or within past 2 weeks
- History of urinary retention
- Known or suggested history of urethral syndrome or painful bladder syndrome
- Prior anti-incontinence surgery
- Prior pelvic surgery with placement of transvaginal mesh
- Known urethral or bladder anomaly including urethral diverticulum or congenital anomalies of the bladder or urethra
- History of genital herpes outbreak within the past 3 months
- Defects in mucosal surfaces including periurethral or vaginal abrasions, ulcerations, or lacerations
- Neurologic disease affecting urethral sensation
- Chronic pelvic pain
- Contraindication or allergy to topical anesthetic
- Pregnancy
- Syncopal episode during preparation for or execution of uroflowometry
Key Trial Info
Start Date :
January 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 29 2019
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT03390790
Start Date
January 25 2018
End Date
March 29 2019
Last Update
July 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Atlantic Health System
Morristown, New Jersey, United States, 07960